The small molecule EGFR/HER2 TKI AP32788 is more specific for HER2 and EGFR with exon 20 insertions relative to WT receptors [36] and is currently being tested in NSCLC tumors harboring these mutations. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.